When was Applied Cells founded?

Applied Cells was founded in 2016.

Where is Applied Cells located?

Applied Cells is headquartered in Santa Clara, United States.

Who is the current CEO of Applied Cells?

Yuchen Zhou of Applied Cells. They have also founded 1 company.

How many employees does Applied Cells have?

As of Aug 31, 2026, the latest employee count at Applied Cells is 11.

Where does Applied Cells rank among its competitors?

Applied Cells ranks 25th amongst 56 active competitors, of which 17 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was ThinkCyte, which secured $14.9M in Aug, 2024.

Who are the top competitors of Applied Cells?

Applied Cells' top competitors include NanoCellect Biomedical, LumaCyte and ThinkCyte. Among them, ThinkCyte secured the most recent funding round in August, 2024.

Applied Cells - 2026 Company Profile, Team, Funding & Competitors

Company Details

Applied Cells provides platform for cell separation. The product provided is MARS which is a system to isolate target cells from biological samples. The features of the system are it has modules enabling a capability to meet every user's cell separation and sample preparation need. The system is suitable for SOP of sample preparation in clinical tests, and SOP of cell manufacturing in cell therapies.

Website: appliedcells.com
Social
Email ID: *****@appliedcells.com
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

Santa Clara, United States

Stage

Funding Raised

Investors

NLVC

Ranked

25^th among 56 active competitors

Employee Count

11 as on Aug 31, 2026

Similar Companies

NanoCellect Biomedical & 65 more

View Applied Cells' full profile

Applied Cells is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
APPLIED CELLS CIN: 821476960 , United States, Active	Dec 31, 1999	-	14 (As on Dec 31, 2024)	-

Applied Cells is a funded company. Applied Cells has 1 institutional investor.

View details of Applied Cells's funding rounds and investors

The founders of Applied Cells is Yuchen Zhou. Yuchen Zhou is the CEO of Applied Cells.

Here are the details of Applied Cells' key team members:

Yuchen Zhou: Founder & CEO of Applied Cells.
Contact Info: 1 email address

View details of Applied Cells's Founder profiles and Board Members

Applied Cells' employee count trend

Applied Cells has 11 employees as of Aug 26. Here is Applied Cells's employee count trend over the years:

Uncover Applied Cells' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Applied Cells include NanoCellect Biomedical, LumaCyte and ThinkCyte. Here is the list of Top 10 competitors of Applied Cells, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NanoCellect Biomedical 2009, San Diego (United States), Series D	Develops flow cytometry and cell sorting technology	$78.1M	Illumina Ventures, Vertical Venture Partners ... & 15 others	62/100
2nd	LumaCyte 2012, Charlottesville (United States), Series B	Provider of microfluidic and optics based instruments	$24.1M	Malvern Panalytical, Asahi Kasei	54/100
3rd	ThinkCyte 2016, Bunkyo (Japan), Series C	Developer of cell sorting and single cell profiling platforms	$83.2M	SPARX Group, ITV & 20 others	51/100
4th	nanoMR 2006, Albuquerque (United States), Acquired	Developed the system for rapid isolation of rare cells	$25.5M	Dow Chemical Company, Sun Mountain Capital ... & 4 others	50/100
5th	Cell Microsystems 2009, Durham (United States), Series B	Developer of a technology to isolate and recover single cells for molecular analysis	$19.1M	Telegraph Hill Partners, Telegraph Hill Partners ... & 4 others	48/100
6th	Silicon Biosystems 1999, Bologna (Italy), Acquired	Developer of lab on a chip technologies for miniaturized cell-biology testing	$25.5M	Indaco Venture Partners, Innogest Capital ... & 1 others	46/100
7th	Immunicon 1983, Bryn Athyn (United States), Acquired	Cell and molecular-based human diagnostic and life science research products for cancer disease management	$75.4M	Canaan, Wheatley Partners & 10 others	44/100
8th	Cellular Highways 2016, Melbourn (United Kingdom), Acquired	Developer of cell sorting device	-	-	44/100
9th	Singulex 1997, Alameda (United States), Series G	Revolutionizing immunodiagnostics with ultra-sensitive technology to transform healthcare	$141M	Orbimed, JAFCO Group & 10 others	43/100
10th	Single Cell Discoveries 2018, Utrecht (Netherlands), Unfunded	Provider of single-cell sequencing-based instrument and services	-	-	43/100
25th	Applied Cells 2016, Santa Clara (United States), Funding Raised	Provider of platform for cell separation	-	NLVC	31/100